Michael Bogart, PharmD

Senior Director, Patient Focused Implementation Science
Gilead Sciences, Inc.

Poster(s):

• (196) Barriers to oral HIV pre-exposure prophylaxis (PrEP) perceived by those receiving an initial prescription: US survey analysis
  Wednesday, October 29, 2025